| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $154,888,899 ) (Continued on the next page) |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01CA298935 | Socioeconomic and adversity-associated immunobiologic influences on pediatric hematopoietic cell transplant outcomes | 000 | 2 | NIH | 4/10/2026 | $625,734 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01AI038903 | T Cell Homeostasis | 000 | 30 | NIH | 1/14/2026 | $449,257 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01HD108059 | Molecular Mechanisms of Regeneration Termination | 001 | 5 | NIH | 4/1/2026 | $32,936 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R24AG065172 | Research Network on Animal Models to Understand Social Dimensions of Aging | 000 | 7 | NIH | 3/26/2026 | $389,076 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01HD108059 | Molecular Mechanisms of Regeneration Termination | 000 | 5 | NIH | 1/21/2026 | $296,429 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01AG075809 | Using a novel mTBI model to investigate phosphorylation dependent common mechanisms in tauopathies | 000 | 5 | NIH | 3/3/2026 | $767,250 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R00NS121274 | Cerebellar computations in health and epilepsy | 000 | 5 | NIH | 2/26/2026 | $249,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01EY034003 | Inflammation in MERTK-dependent retinitis pigmentosa | 001 | 4 | NIH | 4/24/2026 | $640,479 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01HD057929 | National Spatiotemporal Population Research Infrastructure | 000 | 18 | NIH | 3/23/2026 | $665,503 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01CA277714 | Time toxicity of cancer: the time demands of cancer-related activities and their impact on well-being and quality of life | 001 | 4 | NIH | 4/16/2026 | $34,859 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01CA277714 | Time toxicity of cancer: the time demands of cancer-related activities and their impact on well-being and quality of life | 000 | 4 | NIH | 2/9/2026 | $313,738 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM161293 | Cell Context and Variant Effects: Multiplexed Assays for Synthetic Protein Innovation | 000 | 1 | NIH | 3/19/2026 | $492,931 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM161202 | Dynamics of Motile Flagella in Fluid Media | 000 | 1 | NIH | 3/19/2026 | $373,737 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21AI190751 | Development of broadly protective Lassa vaccines using the Pichinde virus vector | 000 | 1 | NIH | 4/9/2026 | $192,500 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31DK146624 | Elucidating the role of ketone bodies in hepatic PUFA homeostasis and MASLD-MASH progression | 000 | 1 | NIH | 3/19/2026 | $35,783 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31DK146624 | Elucidating the role of ketone bodies in hepatic PUFA homeostasis and MASLD-MASH progression | 001 | 1 | NIH | 3/19/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21CA310158 | Therapeutic Restoration of Cholangiocyte Primary Cilia via Microbiota-Derived Butyrate: A Novel Approach for Bile Duct Cancer | 000 | 1 | NIH | 4/9/2026 | $408,829 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31NS149569 | Seizure frequency reduction through Bayesian-optimized cerebellar stimulation and perturbation-based risk modeling | 000 | 1 | NIH | 5/7/2026 | $37,548 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31NS149569 | Seizure frequency reduction through Bayesian-optimized cerebellar stimulation and perturbation-based risk modeling | 001 | 1 | NIH | 5/7/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30AI197932 | Development and Implementation of a Cost-Effective Diagnostic Algorithm to Reduce AIDS-Related Deaths among Hospitalized People with Advanced HIV Disease | 000 | 1 | NIH | 5/6/2026 | $55,114 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM161283 | TERPENE: Titer Enhancement via Refactored Precursor pathways for Natural Produce Discovery | 000 | 1 | NIH | 5/7/2026 | $423,500 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01AI189558 | Defining the Mechanism of Intoxication of the Clostridioides difficile Transferase | 000 | 1 | NIH | 2/19/2026 | $529,512 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM161467 | A comprehensive analytical framework for multi-source, multi-way, and multi-cohort data | 000 | 1 | NIH | 2/27/2026 | $333,290 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R00DA060895 | Mapping the Functional and Anatomical Pathways from the Anterior and Posterior Paraventricular Nucleus of the Thalamus to the Nucleus Accumbens: Implications for Opioid Use | 000 | 2 | NIH | 2/18/2026 | $249,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | K23DK146162 | Technology-Enhanced Adherence to Medication intervention for youth with Type 2 Diabetes (TEAM-T2D) | 000 | 1 | NIH | 3/19/2026 | $177,877 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21DA064314 | Therapeutic potential of M5 receptor targeting in stress-induced potentiation of drug reward | 000 | 1 | NIH | 3/23/2026 | $423,500 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21CA301160 | Circulating senescent proteins and their trajectories in relation to age-related outcomes in cancer survivors | 000 | 1 | NIH | 4/10/2026 | $399,852 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01EB038654 | Technology Development for Whole Brain Functional and Structural Connectivity Mapping at 10.5T | 000 | 1 | NIH | 4/10/2026 | $531,021 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21CA313195 | Single-Cell Signaling Network Profiling of Pooled CRISPR Screens by Mass Cytometry | 000 | 1 | NIH | 5/7/2026 | $406,325 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01EB038350 | Safe, effective, and trustworthy AI for healthcare delivery organizations and populations across the United States | 000 | 1 | NIH | 3/30/2026 | $654,117 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01EB038780 | Dual density-dependent molecular AND gates: ultraselective bispecific targeting via avidity | 000 | 1 | NIH | 4/10/2026 | $471,967 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31AI194928 | Engineering Adeno-associated virus vectors for the in vivo generation of CAR T cells targeting HIV B cell reservoirs | 000 | 1 | NIH | 5/12/2026 | $35,951 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31AI197980 | Human retrovirus assembly interplay with the actin cortex | 000 | 1 | NIH | 4/21/2026 | $48,621 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM162637 | Engineering Immunocompetent Systems for Modeling, Modulating, and Treating Inflammatory Diseases | 000 | 1 | NIH | 3/20/2026 | $398,144 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30CA301797 | Targeting oncogenic KRAS to sensitize pancreatic cancer to NK cell immunotherapy | 000 | 1 | NIH | 3/23/2026 | $47,251 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30CA314114 | Investigating the Role of AR Extrachromosomal DNA (ecDNA) in Bipolar Androgen Therapy for Advanced Prostate Cancer | 000 | 1 | NIH | 5/19/2026 | $44,819 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30CA314114 | Investigating the Role of AR Extrachromosomal DNA (ecDNA) in Bipolar Androgen Therapy for Advanced Prostate Cancer | 001 | 1 | NIH | 5/19/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30CA301797 | Targeting oncogenic KRAS to sensitize pancreatic cancer to NK cell immunotherapy | 002 | 1 | NIH | 4/16/2026 | $576 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30CA301797 | Targeting oncogenic KRAS to sensitize pancreatic cancer to NK cell immunotherapy | 001 | 1 | NIH | 3/23/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01CA308970 | Development of autologous humanized leukemia models for immunotherapy testing | 000 | 1 | NIH | 4/21/2026 | $573,262 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01DA065635 | Regulation of nucleus accumbens microcircuitry by exogenous opioid exposure | 000 | 1 | NIH | 4/28/2026 | $673,724 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01DC023255 | Spectro-temporal interactions in electric and acoustic auditory perception | 000 | 1 | NIH | 3/13/2026 | $596,678 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01DK147762 | Modulation of interoception by TRPV1-expressing renal afferent nerves | 000 | 1 | NIH | 5/15/2026 | $694,934 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R25CA306814 | Biomarker Development and Applications to Inform Cancer Prevention | 000 | 1 | NIH | 3/27/2026 | $309,761 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01DK142604 | A Biologically Based Approach to Prevent Obesity in Older Adolescents and Young Adults | 000 | 1 | NIH | 3/5/2026 | $759,944 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21AI191189 | SysTAMatic mouse model toolbox to disentangle signal transduction pathways | 000 | 1 | NIH | 2/18/2026 | $423,500 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | K08DK143336 | Prophylactic renal denervation for the prevention of tacrolimus nephrotoxicity | 000 | 1 | NIH | 2/13/2026 | $176,028 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01DK143274 | Stromal regulation of pathological bone remodeling | 000 | 1 | NIH | 2/16/2026 | $676,905 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31DA066289 | Angiotensin converting enzyme inhibition as a potential therapeutic intervention for opioid relapse | 000 | 1 | NIH | 5/13/2026 | $37,548 |
|
